New Guidelines for Hypertension Diagnosis and Treatment: An European Perspective.
作者信息
Grassi Guido
机构信息
Clinica Medica, Department of Medicine and Surgery, University Milano-Bicocca, 20052 Milan, Italy.
出版信息
Rev Cardiovasc Med. 2024 Feb 4;25(2):55. doi: 10.31083/j.rcm2502055. eCollection 2024 Feb.
Abstract
摘要
相似文献
1
New Guidelines for Hypertension Diagnosis and Treatment: An European Perspective.高血压诊断与治疗新指南：欧洲视角
Rev Cardiovasc Med. 2024 Feb 4;25(2):55. doi: 10.31083/j.rcm2502055. eCollection 2024 Feb.
2
Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management.2017 ACC/AHA 指南与 2013 ESH/ESC 指南在高血压管理方面的人群影响比较。
Eur J Prev Cardiol. 2018 Jul;25(10):1111-1113. doi: 10.1177/2047487318768938. Epub 2018 Apr 11.
3
4
Population impact of different hypertension management guidelines based on the prospective population-based Heinz Nixdorf Recall study.基于前瞻性人群研究 Heinz Nixdorf Recall 对不同高血压管理指南的人群影响。
BMJ Open. 2021 Feb 17;11(2):e039597. doi: 10.1136/bmjopen-2020-039597.
5
Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations.抗高血压药物与男性性功能障碍：成人高血压指南推荐综述
J Cardiovasc Pharmacol Ther. 2016 May;21(3):233-44. doi: 10.1177/1074248415598321. Epub 2015 Oct 7.
6
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.新的美国或欧洲高血压学会/欧洲心脏病学会高血压指南实施的治疗资格及经济效应
J Hypertens. 2015 Apr;33(4):868-73. doi: 10.1097/HJH.0000000000000466.
7
Hypertension Guidelines: Effect of Blood Pressure Targets.高血压指南：血压目标的影响。
Can J Cardiol. 2019 May;35(5):564-569. doi: 10.1016/j.cjca.2019.03.014. Epub 2019 Mar 21.
8
[What new will implementation of European Guidelines for managing arterial hypertension introduce into real-life clinical practice?].[欧洲动脉高血压管理指南的实施将给实际临床实践带来哪些新变化？]
Kardiologiia. 2019 Aug 23;59(7S):47-52. doi: 10.18087/cardio.2663.
9
Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.正常至高血压人群的管理计划：先前定义为“正常高值血压”人群的降压药物治疗的风险和获益。
Korean J Intern Med. 2019 Jan;34(1):44-49. doi: 10.3904/kjim.2018.382. Epub 2018 Dec 28.
10
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.欧洲肥胖研究学会和欧洲高血压学会联合声明：肥胖与难治性动脉高血压。
J Hypertens. 2012 Jun;30(6):1047-55. doi: 10.1097/HJH.0b013e3283537347.
本文引用的文献
1
Telemedicine and Digital Medicine in the Clinical Management of Hypertension and Hypertension-Related Cardiovascular Diseases: A Position Paper of the Italian Society of Arterial Hypertension (SIIA).高血压及相关心血管疾病临床管理中的远程医疗和数字医疗：意大利动脉高血压学会（SIIA）立场文件。
High Blood Press Cardiovasc Prev. 2023 Sep;30(5):387-399. doi: 10.1007/s40292-023-00595-0. Epub 2023 Aug 18.
2
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组：得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
3
Future treatments in hypertension: Can we meet the unmet needs of patients?高血压的未来治疗方法：我们能否满足患者的未满足需求？
Eur J Intern Med. 2023 Sep;115:18-28. doi: 10.1016/j.ejim.2023.06.008. Epub 2023 Jun 17.
4
Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.基于导管的肾去神经支配：顽固性高血压患者9年安全性及血压降低随访数据
Hypertension. 2023 Apr;80(4):811-819. doi: 10.1161/HYPERTENSIONAHA.122.20853. Epub 2023 Feb 10.
5
10-Year Outcomes of Catheter-Based Renal Denervation in Patients With Resistant Hypertension.顽固性高血压患者经导管肾去神经术的10年随访结果
J Am Coll Cardiol. 2023 Feb 7;81(5):517-519. doi: 10.1016/j.jacc.2022.11.038.
6
Phenotyping the hypertensive heart.高血压心脏表型。
Eur Heart J. 2022 Oct 11;43(38):3794-3810. doi: 10.1093/eurheartj/ehac393.
7
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines.由合并症决定的高血压个体化β受体阻滞剂治疗：2018年欧洲心脏病学会/欧洲高血压学会指南之外的适应症
Hypertension. 2022 Jun;79(6):1153-1166. doi: 10.1161/HYPERTENSIONAHA.122.19020. Epub 2022 Apr 5.
8
Research strategies in treatment of hypertension: value of retrospective real-life data.高血压治疗的研究策略：回顾性真实数据的价值。
Eur Heart J. 2022 Sep 14;43(35):3312-3322. doi: 10.1093/eurheartj/ehab899.
9
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement.注意和非注意血压测量的交感神经机制。
Hypertension. 2021 Sep;78(4):1126-1133. doi: 10.1161/HYPERTENSIONAHA.121.17657. Epub 2021 Aug 9.
10
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
Zotero 插件